Clinical Trial Update: NXC-201 (formerly HBI0101) Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 trial of NXC-201 (formerly HBI0101) for multiple myeloma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• NXC-201

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Dose Escalation and Safety | Phase 1 | Status: ACTIVE_NOT_RECRUITING